Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439808/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439808/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome. Accessed January 16, 2025.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439808/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439808/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
ID - 439808
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439808/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -